RAPPRapport Therapeutics, Inc.

Nasdaq www.rapportrx.com


$ 23.69 $ -1.60 (-6.33 %)    

Wednesday, 03-Jul-2024 12:53:35 EDT
QQQ $ 490.55 $ 4.08 (0.84 %)
DIA $ 393.04 $ -0.73 (-0.19 %)
SPY $ 551.42 $ 2.82 (0.51 %)
TLT $ 91.78 $ 0.61 (0.67 %)
GLD $ 217.90 $ 0.59 (0.27 %)
$ 25.01
$ 25.29
$ 23.50 x 100
$ 0.00 x 0
$ 23.17 - $ 25.29
$ 18.00 - $ 27.11
227,599
na
0
$ 9.93
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

TD Cowen analyst Joseph Thome initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating.

Core News & Articles

Jefferies analyst Andrew Tsai initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating and announces Price...

Core News & Articles

Stifel analyst Paul Matteis initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating and announces Price T...